Genedx Holdings Corp. · NASDAQ:WGS
Stueland Katherine sold 2,172 Genedx Holdings Corp. shares (Form 4)
Traded Apr 29, 2026 · Filed May 1, 2026
On Apr 29, 2026, Stueland Katherine (Director, CHIEF EXECUTIVE OFFICER) sold 2,172 Genedx Holdings Corp. shares at an average US$65.19 for US$142K, leaving 93,216 shares. Filed May 1, 2026 (Form 4).
- Sold
- 2,172 shares
- Price
- US$65.19 average (US$64.12 to US$65.20)
- Value
- US$142K
- Holding after
- 93,216 shares
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | Class A Common Stock | Option exercise | 3,874 | 95,388 | Direct | |
| Apr 29, 2026 | Class A Common Stock | Sale | 2,154 | US$65.20 | 93,234 | Direct |
| Apr 29, 2026 | Class A Common Stock | Sale | 18 | US$64.12 | 93,216 | Direct |
Source
Related
- Genedx Holdings Corp.
- Stueland Katherine
- Genedx Holdings Corp. shareholders
- Form 4 · Stueland Katherine · Sep 18, 2026
- Form 4 · Stueland Katherine · Sep 11, 2026
- Form 4 · Stueland Katherine · Jun 18, 2026
- Form 4 · Stueland Katherine · Jun 11, 2026
- Form 4 · Fuchs Thomas · Sep 18, 2026
- Form 4 · Feeley Kevin · Sep 18, 2026
- Form 4 · Feeley Kevin · Sep 11, 2026
- Form 4 · Feeley Kevin · Sep 3, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 11, 2026